• Member Login
  • Become a Member
  • Database Search
IATI - Israel Advanced Technology Industries
IATI - Israel Advanced Technology Industries
IATI Database Life Science Companies Biotechnology BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

IATI Member

Website: http://www.brainstorm-cell.com

Category: Biotechnology
Sub-category: Tissue Engineering & Cell Therapy
Medical field: Neurology and Degenerative Disease
Est.: 2004
Stage: Clinical

BrainStorm is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson's Disease (PD).

BrainStorm's novel stem cell treatment, NurOwnâ, induces the patient's mesenchymal stem cells (MSC) to secrete elevated levels of neurotrophic factors. These neuron-supporting cells are then transplanted back into the patient's spine and/or muscles. The company treated 26 patients in two clinical trials conducted at Hadassah Medical Center in Jerusalem, and is currently launching a multi-center Phase II ALS clinical trial in the USA. The company holds the rights to develop and commercialize NurOwn through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University.

Contact Person Chaim Lebovits, CEO
General Email ygothelf@brainstorm-cell.com
Address Rehov Basel 12, Peatch Tikva
Phone 972-3-923-6384 ext 111

To update your company data, click here.
| Terms of Use | Privacy Policy | Sitemap